The Journal of Immunology, Vol 151, Issue 1 20-28, Copyright © 1993 by American Association of Immunologists

ARTICLES

Altered protein tyrosine phosphorylation in anergic Th1 cells

EA Cho, MP Riley, AL Sillman and H Quill
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104.

Clonal anergy as a mechanism for tolerance in T lymphocytes can be studied using an in vitro culture system, in which cloned CD4+ Th1-type murine T cells are rendered anergic for IL-2 transcription. The long- lasting molecular changes in anergic cells that prevent the response to Ag restimulation are not yet known. To determine whether the TCR might be uncoupled from normal intracellular signaling pathways, we investigated the response of anergic T cells to Ag, to anti-CD3 antibodies, or to anti-CD4 antibody restimulation in terms of early protein tyrosine phosphorylation events. Tyrosine phosphorylation of the CD3 zeta chain was apparently normal. In contrast, defects in the induction of tyrosine phosphorylation of three major T cell protein substrates were demonstrated. Altered phosphorylation correlated with functional nonresponsiveness for proliferation and reversal of anergy by growth in exogenous IL-2 resulted in reversal of the phosphorylation defects as well as in recovery of Ag responsiveness. These results suggest that specific defects in tyrosine phosphorylation pathways required for the induction of IL-2 synthesis may help to explain nonresponsiveness to Ag in tolerant T cells.

This article has been cited by other articles:

				D. S. Pouniotis, O. Proudfoot, V. Bogdanoska, K. Scalzo, S. Kovacevic, R. L. Coppel, and M. Plebanski Selectively Impaired CD8+ but Not CD4+ T Cell Cycle Arrest during Priming as a Consequence of Dendritic Cell Interaction with Plasmodium-Infected Red Cells J. Immunol., September 15, 2005; 175(6): 3525 - 3533. [Abstract] [Full Text] [PDF]

				P. HASLER and M. ZOUALI B cell receptor signaling and autoimmunity FASEB J, October 1, 2001; 15(12): 2085 - 2098. [Abstract] [Full Text] [PDF]

				O. Utting, S.-J. Teh, and H.-S. Teh A Population of In Vivo Anergized T Cells with a Lower Activation Threshold for the Induction of CD25 Exhibit Differential Requirements in Mobilization of Intracellular Calcium and Mitogen-Activated Protein Kinase Activation J. Immunol., March 15, 2000; 164(6): 2881 - 2889. [Abstract] [Full Text] [PDF]

				D. G. Telander, E.-N. Malvey, and D. L. Mueller Evidence for Repression of IL-2 Gene Activation in Anergic T Cells J. Immunol., February 1, 1999; 162(3): 1460 - 1465. [Abstract] [Full Text] [PDF]

				Y. Yang, J.-F. Chang, J. R. Parnes, and C. Garrison Fathman T Cell Receptor (TCR) Engagement Leads to Activation-induced Splicing of  Tumor Necrosis Factor (TNF) Nuclear Pre-mRNA J. Exp. Med., July 20, 1998; 188(2): 247 - 254. [Abstract] [Full Text] [PDF]

				H. Luo, H. Chen, S. Qi, D. Loh, P. Daloze, A. Veillette, D. Xu, and J. Wu De Novo-Developed T Cells Have Compromised Response to Existing Alloantigens: Using Ld-Specific Transgenic 2C T Cells as Tracers in a Mouse Heart Transplantation Model J. Immunol., July 1, 1998; 161(1): 73 - 82. [Abstract] [Full Text] [PDF]

				Y. D. Korin and J. A. Zack Progression to the G1b Phase of the Cell Cycle Is Required for Completion of Human Immunodeficiency Virus Type 1 Reverse Transcription in T Cells J. Virol., April 1, 1998; 72(4): 3161 - 3168. [Abstract] [Full Text] [PDF]

				R. J. Hayashi, D. Y. Loh, O. Kanagawa, and F. Wang Differences Between Responses of Naive and Activated T Cells to Anergy Induction J. Immunol., January 1, 1998; 160(1): 33 - 38. [Abstract] [Full Text] [PDF]

				J Madrenas, R. Wange, J. Wang, N Isakov, L. Samelson, and R. Germain Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists Science, January 27, 1995; 267(5197): 515 - 518. [Abstract] [PDF]